发明名称 COMBINED CHEMOTHERAPY TO HIV INFECTION
摘要 PURPOSE: To prepare a medicine hardly causing side effects, attacking to a virus, excellent in immune response and useful for treatment of human HIV- infected patient by including prescribed amounts of thymosine, etc., and HIV replication inhibitor compound, etc., in each free form. CONSTITUTION: The objective medicine comprises (A) a thymosine such as THN-α1, one or more kinds of interleukin such as IL-2 and PEG-1L-2 or its active derivative in an amount for stimulating an immune system which is the amount of the thymosine and the interleukin capable of increasing >=10% number of CD4<+> cells, and (B) an effective amount of one or more kinds of inhibitors of inhibitor compounds of reverse transcriptase such as pyridine nucleotide analogue and nevirapine reducing HIV replication or enzyme activities by mutually acting on the reverse transcriptase, in each free shape. Preferably, the THN-α1 of 1-2 mg is subcutaneously administered twice per week, IL-2 of 1.5-12×10<6> IU/m<2> is successively, peripherally intravenously administered and ZDV (an HIV replication inhibitor) of 500 mg/day is orally administered.
申请公布号 JPH07267874(A) 申请公布日期 1995.10.17
申请号 JP19930314746 申请日期 1993.12.15
申请人 UNIV LELAND STANFORD JR;UNIV GEORGE WASHINGTON 发明人 TOOMASU SHII MERIGAN;ROBIN UTSUDO;ARAN ERU GOORUDOSUTAIN
分类号 A61K38/00;A61K31/55;A61K31/70;A61K38/22;A61P31/12;A61P31/18;(IPC1-7):A61K38/00 主分类号 A61K38/00
代理机构 代理人
主权项
地址